McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

Analyst’s Disclosure: I/we have a beneficial long position in the shares of MCK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any in ...